Article Details

Amgen - AstraZeneca's Asthma Candidate Under Priority Review With FDA

Retrieved on: 2021-07-08 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

Amgen - AstraZeneca's Asthma Candidate Under Priority Review With FDA. View article details on hiswai:

Excerpt

Amgen is developing Tezepelumab in collaboration with AstraZeneca plc (NASDAQ: AZN). Under priority review status, the agency's goal date for a ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up